{"gene":"PAX6","run_date":"2026-06-10T05:19:53","timeline":{"discoveries":[{"year":1992,"finding":"PAX6 spans 22 kilobases and is divided into 14 exons; intragenic mutations (including nonsense and frameshift) in PAX6 cause human aniridia, establishing that aniridia results from loss-of-function of the PAX6 gene.","method":"cDNA cloning, intron-exon mapping, direct sequencing of aniridia patient DNA","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — genomic structure determined by cloning, mutations confirmed by sequencing in multiple independent patients, replicated across labs","pmids":["1345175"],"is_preprint":false},{"year":1990,"finding":"Chromosomal mapping placed the mouse Small eye (Sey) gene on chromosome 2 in a region syntenic with human chromosome 11p13, where the aniridia locus AN2 resides, establishing that Sey is the mouse homolog of human PAX6/AN2.","method":"Interspecific backcross linkage mapping","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic mapping with multiple markers, single study, later confirmed by mutation identification","pmids":["2347591"],"is_preprint":false},{"year":1992,"finding":"The originally proposed AN1 locus on chromosome 2p for autosomal dominant aniridia was shown by linkage analysis to be misassigned; all aniridia maps to a single locus at 11p13 corresponding to PAX6/AN2.","method":"Linkage analysis with chromosome 2p and 11p13 markers in expanded aniridia kindred","journal":"Genomics","confidence":"High","confidence_rationale":"Tier 2 / Strong — rigorous linkage analysis excluding 2p and confirming 11p13, replicated across multiple families","pmids":["1505982"],"is_preprint":false},{"year":1996,"finding":"Pax6 acts cell-autonomously in the optic cup and controls the fate of surface ectoderm giving rise to lens and nasal epithelium; Pax6-mutant cells were excluded from the lens, nasal epithelium, and retinal pigmented epithelium in chimeric embryos, and did not intermix normally in other retinal regions.","method":"Chimeric mouse embryo analysis (wild-type + Sey mutant cells)","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct chimera experiments demonstrating cell-autonomous function, replicated across multiple chimeras","pmids":["8600027"],"is_preprint":false},{"year":1999,"finding":"Pax6 is required for cell migration and neurite extension of rhombic lip-derived neurons; Pax6-null embryos show disruption of three of five precerebellar nuclei and absence of granule cell pre-migratory sub-layer, associated with complete loss of Unc5h3 (netrin receptor) expression, placing Pax6 upstream of Unc5h3 in hindbrain migration.","method":"Analysis of Pax6(Sey/Sey) null mouse embryos; in situ hybridization for Unc5h3","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic loss-of-function with defined cellular and molecular phenotype, downstream target identified","pmids":["10409504"],"is_preprint":false},{"year":1999,"finding":"Pax6 restricts ventro-dorsal cell migration in the developing telencephalon; loss of Pax6 strongly enhances invasion of cortex by cells from the ganglionic eminence, demonstrating Pax6 functions to maintain the cortico-striatal boundary.","method":"Adenoviral GFP focal injection to track cell migration in wild-type vs. Pax6 mutant (Small Eye) mouse telencephalon","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct cell-tracking experiment in vivo in null mutant, quantified cell migration with clear phenotypic readout","pmids":["10572034"],"is_preprint":false},{"year":1999,"finding":"Pax6 is regulated by two distinct promoters (P0 and P1) that direct differential expression in the developing eye; P0-initiated transcripts predominate in lens placode and corneal/conjunctival epithelia, while P1-initiated transcripts are expressed in lens placode, optic vesicle, and CNS. Multiple cis-acting elements (including one in intron 4) combinatorially control tissue-specific expression.","method":"Transgenic mouse reporter assays with promoter-deletion constructs","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — functional dissection using multiple transgenic lines, two independent promoters mapped with defined regulatory elements","pmids":["9847251"],"is_preprint":false},{"year":1999,"finding":"Pax6 homeodomain (HD) physically interacts with TATA-box-binding protein (TBP), mediated by the N-terminal arm and first two alpha-helices of the HD plus the C-terminal activation domain; Pax6 HD also interacts with retinoblastoma protein (Rb), and Pax6/Rb complexes were detected in lens nuclear extracts.","method":"Affinity chromatography, GST pull-down assays, immunoprecipitation from lens nuclear extracts","journal":"Investigative ophthalmology & visual science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal pull-downs and immunoprecipitation, single lab, multiple binding assays","pmids":["10359315"],"is_preprint":false},{"year":2000,"finding":"A critical threshold of PAX6 protein is required for lens placode formation; heterozygous Pax6 mutation causes a delay in lens placode formation, failure of N-cadherin expression at the lens cup edge, and apoptosis, not due to monoallelic expression (shown to be biallelic by allelic expression analysis).","method":"Analysis of Pax6(Sey-1Neu)/+ heterozygous embryos; cell counting, mitotic index, apoptosis assays, allele-specific expression analysis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (histology, cell counts, apoptosis, allelic expression), mechanistic conclusion about dosage threshold","pmids":["11076764"],"is_preprint":false},{"year":2001,"finding":"Pax6 controls cytoskeletal organization and polarity of cerebellar granule cells; Pax6 mutant rat granule cells fail to form parallel fiber axons and migrate tangentially, sprouting multiple neurites with enlarged growth cones. This effect is cell-autonomous and rescuable by ectopic Pax6 expression, and is independent of ROCK-mediated Rho GTPase signaling.","method":"Analysis of Pax6 mutant rats (rSey2/rSey2); granule cell culture; rescue by ectopic Pax6 expression; ROCK pathway inhibition","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function phenotype with cell-autonomous rescue and pathway exclusion, multiple methods","pmids":["11688562"],"is_preprint":false},{"year":2002,"finding":"Pax6 and Emx2 mutually down-regulate each other's expression in the developing cortex; loss of Emx2 or Pax6 reduces their respective cortical regions and impairs WNT signaling center at the medial-caudal cortical edge.","method":"Analysis of Emx2 and Pax6 loss-of-function mouse mutants; molecular marker expression","journal":"Cerebral cortex (New York, N.Y. : 1991)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function, multiple molecular markers, single lab","pmids":["11739261"],"is_preprint":false},{"year":2002,"finding":"Six3 and Pax6 mutually activate each other's expression in the developing lens: Six3 binds regulatory sequences of Pax6 and Pax6 binds regulatory sequences of Six3 (in vitro and transgenic approaches). Rescue of the Pax6 haploinsufficient lens phenotype by lens-specific Six3 overexpression activates the PDGF-alpha-R/cyclin D1 proliferative pathway.","method":"In vitro binding assays (EMSA), transgenic mouse reporter assays, Pax6+/- rescue transgenic mice","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — EMSA plus transgenic functional rescue, multiple orthogonal methods, mechanistic pathway identified","pmids":["12072567"],"is_preprint":false},{"year":2003,"finding":"Pax6 regulates cell adhesion in the developing cerebral cortex in a cell-autonomous manner; Pax6-deficient cortical cells segregate from wild-type cells and form dense clusters after transplantation into wild-type cortex, and show enhanced clustering in explant migration assays.","method":"Cell transplants into wild-type embryonic cortex; explant migration assays with Pax6(Sey/Sey) cells","journal":"Cerebral cortex (New York, N.Y. : 1991)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — cell-autonomous demonstration via transplantation and explant culture, single lab","pmids":["12764036"],"is_preprint":false},{"year":2003,"finding":"Pax6 regulates radial migration of neuronal precursors, specifically affecting movement at the subventricular zone/intermediate zone boundary; chimera analysis shows Pax6-deficient cells are specifically reduced in the mediocaudal cortical domain, indicating a role in regionalization alongside migration.","method":"Mouse chimera analysis (wild-type + Pax6-deficient cells); BrdU labeling and cell distribution analysis","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — chimera analysis with specific migration phenotype, single lab","pmids":["12618140"],"is_preprint":false},{"year":2004,"finding":"Pax6 is genetically upstream of En1 (Engrailed 1) in Renshaw cell development; Pax6 is required for an early step in Renshaw cell specification, while En1 (downstream of Pax6) regulates inhibitory synapse formation between Renshaw cells and motor neurons.","method":"Analysis of Pax6 and En1 mutant mice; genetic epistasis; immunohistochemistry","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis established by double-mutant analysis, single lab","pmids":["14762144"],"is_preprint":false},{"year":2004,"finding":"Sustained ectopic Pax6 expression in lens fiber cells disrupts differentiation: it reduces cMaf protein levels and dramatically decreases betaB1-crystallin expression, demonstrating that downregulation of Pax6 is required for normal fiber cell differentiation and that Pax6 negatively regulates cMaf.","method":"Transgenic mice with alphaA-crystallin promoter-driven Pax6; 2D gel electrophoresis, immunohistochemistry, RT-PCR, in situ hybridization","journal":"Investigative ophthalmology & visual science","confidence":"High","confidence_rationale":"Tier 2 / Strong — gain-of-function transgenic mice with multiple orthogonal readouts identifying downstream target (cMaf)","pmids":["15452066"],"is_preprint":false},{"year":2004,"finding":"PAX6 and PAX6(5a) transactivation is modulated by specific cellular environments and the location/type of missense mutation; DNA binding by PAX6 homeodomain is required for full function, and a C-terminal missense mutation (Q422R) abolishes homeodomain DNA binding.","method":"Site-directed mutagenesis, transfection reporter assays in four cell lines, EMSA","journal":"Investigative ophthalmology & visual science","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro mutagenesis combined with DNA-binding assays and transactivation in multiple cell lines, single lab","pmids":["14744876"],"is_preprint":false},{"year":2001,"finding":"Missense mutation Q422R at the C-terminus of PAX6 specifically abolishes homeodomain DNA binding of intact PAX6, demonstrating that the C-terminal amino acid modulates homeodomain function; paired domain DNA binding is separately disrupted by the P375Q mutation.","method":"Site-directed mutagenesis of PAX6; electrophoretic mobility shift assays; transfection reporter assays","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro mutagenesis with DNA binding assays, mechanistically informative, single lab","pmids":["11309364"],"is_preprint":false},{"year":2005,"finding":"Pax6 directly binds the proximal promoter of Optimedin (Olfactomedin 3) through its paired domain at position -86/-70, activates Optimedin transcription, and occupies this site in vivo; mutations abolishing the binding site eliminate both Pax6 binding and promoter activation.","method":"EMSA, site-directed mutagenesis, transfection luciferase reporter assay, chromatin immunoprecipitation (ChIP)","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro binding with mutagenesis plus in vivo ChIP confirmation, multiple orthogonal methods","pmids":["16115881"],"is_preprint":false},{"year":2006,"finding":"HIPK2 phosphorylates PAX6 at threonines 281, 304, and 373 in the C-terminal activation domain, enhancing Pax6 transactivation by promoting its interaction with p300; HIPK2 knockdown inhibits Pax6 phosphorylation and its transactivating function on the proglucagon promoter.","method":"Mass spectrometry identification of phosphorylation sites; site-directed mutagenesis (T→A, T→E); HIPK2 shRNA knockdown; co-immunoprecipitation; transactivation assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — MS identification of sites plus mutagenesis validation, co-IP, and knockdown, multiple orthogonal methods","pmids":["16407227"],"is_preprint":false},{"year":2006,"finding":"Six3 directly activates Pax6 (and Sox2) expression in the presumptive lens ectoderm, placing Six3 upstream of Pax6 at the top of the lens formation regulatory pathway; confirmed by ChIP, EMSA, luciferase reporter assay, and Six3 conditional deletion causing Pax6 downregulation.","method":"Conditional deletion of Six3 in presumptive lens ectoderm; ChIP; EMSA; luciferase reporter assay; chick misexpression","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal methods (ChIP, EMSA, reporter, in vivo deletion, ectopic expression), single rigorous study","pmids":["17066077"],"is_preprint":false},{"year":2006,"finding":"Pax6 pancreatic expression is controlled by a minimal enhancer containing a composite Meis-Pbx binding site; Meis and Pbx proteins form a synergistic complex on this enhancer, and both sites are required for enhancer activity in transgenic mice; Pax6 pancreatic expression becomes dependent on Pbx1/Pbx2 during islet formation.","method":"Enhancer deletion analysis; EMSA; transgenic mouse reporter assays; Pbx1/Pbx2 knockout analysis","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 1 / Strong — EMSA, transgenic functional validation, and genetic knockout, multiple methods in single study","pmids":["17049510"],"is_preprint":false},{"year":2009,"finding":"Pax6 is essential for lens fiber cell differentiation and cell cycle exit; conditional Pax6 inactivation in developing mouse lens leads to failure of secondary fiber differentiation, apoptosis of lens epithelial cells, and upregulation of Wnt antagonist Sfrp2 (a Pax6 target); the differentiation failure is independent of beta-catenin signaling or Sox2 activity.","method":"Cre/loxP conditional knockout in mouse lens; histology; gene expression analysis; pathway rescue experiments","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with pathway exclusion experiments, multiple molecular readouts","pmids":["19570848"],"is_preprint":false},{"year":2009,"finding":"Pax6 controls cell proliferation during newt lens regeneration; Pax6 morpholino knockdown dramatically reduces proliferation of iris pigment epithelial cells both in vitro and in vivo, retarding lens regeneration and inhibiting early crystallin expression and lens fiber induction.","method":"Morpholino knockdown in newt; BrdU proliferation assays in vitro and in vivo; crystallin immunohistochemistry","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — morpholino knockdown with multiple functional readouts, single lab","pmids":["17003134"],"is_preprint":false},{"year":2009,"finding":"PAX6 heterozygosity causes cytoskeletal and cell adhesion defects in corneal epithelium resembling a chronic wound state: Pax6+/- corneas show altered desmoplakin and actin localization, protein oxidation, and ERK1/2 and p38 MAPK phosphorylation similar to wounded wild-type corneas.","method":"Immunohistochemistry and electron microscopy of Pax6+/- mouse corneas and wounded wild-type corneas; protein oxidation assays; MAPK phosphorylation analysis","journal":"Investigative ophthalmology & visual science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct comparison of mutant and wounded tissue with multiple molecular markers, single lab","pmids":["19933176"],"is_preprint":false},{"year":2009,"finding":"Pax6 regulates the proglucagon processing enzyme PC2 and its chaperone 7B2 in pancreatic alpha cells: Pax6 indirectly regulates PC2 transcription through cMaf and Beta2/NeuroD1, while it activates 7B2 both directly and indirectly through these same transcription factors.","method":"Pax6 siRNA knockdown and dominant-negative Pax6 in InR1G9 alpha cells; binding and transactivation studies; promoter analysis","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RNAi knockdown with binding and transactivation assays identifying indirect pathway, single lab","pmids":["19223471"],"is_preprint":false},{"year":2010,"finding":"PAX6 is a transcriptional determinant of human neuroectoderm: PAX6 knockdown blocks NE specification from hESCs; only PAX6a (not PAX6b or PAX6deltaPD) converts hESCs to NE; PAX6a binds to NE gene promoters during human NE specification while PAX6b only binds pluripotency gene promoters.","method":"hESC differentiation; Pax6 knockdown; overexpression of isoforms; chromatin immunoprecipitation; promoter binding analysis","journal":"Cell stem cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function and isoform-specific gain-of-function with ChIP defining isoform-specific target genes, multiple orthogonal methods","pmids":["20621053"],"is_preprint":false},{"year":2013,"finding":"Pax6 regulates hindbrain segmentation by repressing Krox20 expression domains; Pax6 and Krox20 engage in mutual negative cross-talk through Pax6-mediated regulation of the Krox20 repressor Nab1; FGF signaling acts upstream of the Pax6-Krox20 network.","method":"Gain- and loss-of-function approaches in chick and mice; in situ hybridization; boundary analysis","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple gain/loss-of-function approaches in two species identifying Nab1 as intermediate, single lab","pmids":["23578930"],"is_preprint":false},{"year":2014,"finding":"WNT7A controls corneal epithelium differentiation through PAX6; PAX6 together with p63 specifies limbal stem cells; loss of WNT7A or PAX6 converts limbal stem cells to a skin-like epithelium; transduction of PAX6 into skin epithelial stem cells is sufficient to convert them to LSC-like cells capable of repairing corneal surface after transplantation.","method":"In vitro feeder-free LSC expansion; 3D corneal differentiation; PAX6 lentiviral transduction; rabbit corneal injury transplantation model","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — gain-of-function and loss-of-function with in vivo functional transplantation validation, multiple orthogonal methods","pmids":["25030175"],"is_preprint":false},{"year":2015,"finding":"Onecut1 and Onecut2 transcription factors operate downstream of Pax6 in retinal horizontal cell development; Pax6 inactivation in retinal progenitors leads to loss of Onecut1/2 expression, and Onecut-deficient retinae completely lack horizontal cells, placing Pax6 → Onecut1/2 → horizontal cell maintenance.","method":"Pax6 conditional knockout; Onecut1/Onecut2 single and compound mutants; immunohistochemistry for horizontal cell markers (Foxn4, Ptf1a, Prox1, Lim1)","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis established by conditional knockout and compound mutants, single lab","pmids":["25794677"],"is_preprint":false},{"year":2016,"finding":"PAX6 maintains adult beta cell identity by directly activating beta cell genes and repressing alternative islet cell genes (ghrelin, glucagon, somatostatin); beta-cell-specific Pax6 deletion causes lethal hyperglycemia and expansion of alpha cells; lineage tracing and chromatin analysis confirm direct PAX6 binding at promoters and enhancers of repressed genes.","method":"Conditional Pax6 deletion in adult beta cells; lineage tracing; transcriptome analysis; chromatin immunoprecipitation; shRNA in human islets","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with lineage tracing, chromatin analysis, and human beta cell validation — multiple orthogonal methods","pmids":["27941241"],"is_preprint":false},{"year":2016,"finding":"Pax6 targets a large number of promoters in neural progenitor cells, many co-occupied with Sox2; Pax6 activates neuronal/ectodermal genes while concurrently repressing mesodermal and endodermal genes, ensuring unidirectional neuronal lineage commitment; Pax6 directly binds and activates Ift74, whose knockdown impairs polarity and migration of newborn neurons.","method":"ChIP-seq; transcriptome analysis in Pax6-deficient neural progenitors; in utero knockdown of Ift74","journal":"Cell discovery","confidence":"High","confidence_rationale":"Tier 2 / Strong — genome-wide ChIP combined with transcriptome and in vivo functional validation of downstream target","pmids":["27462442"],"is_preprint":false},{"year":2016,"finding":"PAX6 knockout in human corneal epithelial cells (CRISPR/Cas9) leads to downregulation of cornea-specific genes (KRT12, KRT3, CLU, ALDH3A1, ANGPTL7, TKT) and upregulation of epidermis-related genes (KRT10, KRT1, IVL, FLG), demonstrating PAX6 maintains corneal epithelial cell identity.","method":"CRISPR/Cas9 PAX6 knockout in human corneal epithelial cells; microarray transcriptome analysis","journal":"Experimental eye research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — CRISPR KO with genome-wide expression analysis, single lab","pmids":["27818314"],"is_preprint":false},{"year":2021,"finding":"PAX6 is upregulated in Alzheimer's disease brains downstream of amyloid-β/E2F1/c-Myb signaling and directly regulates GSK-3β transcription, promoting tau hyperphosphorylation at Ser356, Ser396, and Ser404; PAX6 downregulation protects against amyloid-β-induced neuronal death.","method":"Analysis of AD brains and APP transgenic mice; PAX6 knockdown; ChIP for E2F1, c-Myb, and PAX6 binding to GSK-3β promoter; tau phosphorylation assays","journal":"Brain : a journal of neurology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP, knockdown with functional readout, single lab, multiple molecular readouts","pmids":["34428276"],"is_preprint":false},{"year":2021,"finding":"The lncRNA PAUPAR interacts with PAX6 to confer proper binding sites on target neural genes; PAX6 recruits histone methyltransferase NSD1 through its C-terminal PST domain to regulate H3K36 methylation and expression of neural target genes during cortical differentiation.","method":"hESC neural differentiation; PAUPAR knockdown; ChIP; co-immunoprecipitation; 3D cerebral organoid system","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — co-IP and ChIP demonstrating complex, single lab, mechanism partially resolved","pmids":["33544864"],"is_preprint":false},{"year":2018,"finding":"Drosophila Eyeless/Pax6 acts non-autonomously from the peripodial epithelium to control eye pattern formation by regulating decapentaplegic (dpp) expression, which is required for morphogenetic furrow initiation in the eye disc; loss of Ey in peripodial cells abolishes dpp expression and retinal development.","method":"Clonal analysis and targeted Ey knockdown/knockout in Drosophila peripodial epithelium; in situ hybridization for dpp","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function with molecular identification of downstream target (dpp), non-cell-autonomous mechanism, single lab","pmids":["29980566"],"is_preprint":false}],"current_model":"PAX6 is a dosage-sensitive paired-box/homeodomain transcription factor that acts as a master regulator of eye, brain, and pancreas development by directly binding DNA through its paired domain and homeodomain to activate tissue-specific genes (e.g., crystallins, Optimedin, beta cell genes, GSK-3β) and repress alternative lineage genes; its transcriptional activity is enhanced by HIPK2-mediated phosphorylation at T281/T304/T373 (promoting p300 interaction), regulated by a lncRNA PAUPAR/NSD1 complex, and controlled by upstream activators including Six3 and Meis/Pbx; it functions cell-autonomously to regulate cell adhesion, migration, and cytoskeletal organization in multiple developmental contexts, and haploinsufficiency of PAX6 causes aniridia and related ocular and pancreatic dysfunction."},"narrative":{"mechanistic_narrative":"PAX6 is a dosage-sensitive paired-domain/homeodomain transcription factor that serves as a master regulator of eye, brain, and pancreas development, acting cell-autonomously to specify and maintain tissue identity, control cell adhesion and migration, and govern lineage commitment [PMID:8600027, PMID:20621053, PMID:27941241]. It binds DNA through both its paired domain and homeodomain — each required for full activity, since the C-terminal Q422R mutation abolishes homeodomain binding and P375Q disrupts paired-domain binding [PMID:14744876, PMID:11309364] — to directly activate tissue-specific target genes such as Optimedin in the eye and beta-cell genes in the pancreas, while concurrently repressing alternative-lineage programs [PMID:16115881, PMID:27941241, PMID:27462442]. In the developing eye PAX6 sits within mutually reinforcing regulatory loops with Six3, and dosage is tightly controlled: a critical protein threshold is required for lens placode formation, and haploinsufficiency produces lens, corneal, and migration defects [PMID:11076764, PMID:12072567, PMID:17066077]. PAX6 enforces neuroectodermal fate in human cells in an isoform-specific manner, with PAX6a—but not PAX6b—binding neuroectoderm gene promoters and co-occupying targets with Sox2 to drive unidirectional neuronal commitment while repressing mesodermal and endodermal genes [PMID:20621053, PMID:27462442]. It maintains epithelial identity in the cornea, where it specifies limbal stem cells and where its loss converts corneal to skin-like epithelium [PMID:25030175, PMID:27818314], and it maintains adult pancreatic beta-cell identity, repressing alpha/delta-cell genes such that beta-cell deletion causes lethal hyperglycemia [PMID:27941241]. PAX6 transcriptional output is tuned by post-translational and cofactor mechanisms: HIPK2 phosphorylates it at T281/T304/T373 to promote p300 interaction and transactivation, and it recruits the histone methyltransferase NSD1 (in concert with the lncRNA PAUPAR) through its C-terminal PST domain to deposit H3K36 methylation at neural targets [PMID:16407227, PMID:33544864]. Loss-of-function mutations in PAX6 cause human aniridia, which maps to a single locus at 11p13 [PMID:1345175, PMID:1505982].","teleology":[{"year":1992,"claim":"Establishing the genetic basis of aniridia: linkage and mutation analysis resolved that all autosomal dominant aniridia maps to a single 11p13 locus and that loss-of-function mutations in PAX6 are causative, defining PAX6 as a haploinsufficient disease gene.","evidence":"Interspecific backcross mapping of mouse Sey, expanded-kindred linkage analysis, and cDNA cloning with direct sequencing of aniridia patient DNA","pmids":["2347591","1505982","1345175"],"confidence":"High","gaps":["Did not define the molecular DNA-binding mechanism","Did not establish the downstream target genes affected"]},{"year":1996,"claim":"Resolving whether PAX6 acts within cells or on their environment: chimera analysis showed Pax6 functions cell-autonomously to control surface ectoderm fate and intermixing, framing it as an intrinsic determinant of lens, nasal, and retinal lineages.","evidence":"Chimeric mouse embryos combining wild-type and Sey mutant cells","pmids":["8600027"],"confidence":"High","gaps":["Did not identify direct transcriptional targets mediating cell-autonomy","Non-autonomous roles in other tissues not excluded"]},{"year":1999,"claim":"Defining PAX6 as a regulator of neuronal migration and cytoskeletal organization: loss-of-function in hindbrain, telencephalon, and cerebellar granule cells revealed roles in cell migration, polarity, and neurite extension, with Unc5h3 identified as a downstream target.","evidence":"Pax6-null and Small Eye mouse/rat analysis, focal GFP cell tracking, granule cell culture with rescue, and in situ hybridization for Unc5h3","pmids":["10409504","10572034","11688562"],"confidence":"High","gaps":["Mechanistic link between PAX6 transcription and cytoskeletal change incomplete","Direct vs indirect regulation of Unc5h3 not resolved"]},{"year":1999,"claim":"Mapping how PAX6 expression itself is controlled and how PAX6 contacts the transcription machinery: dual promoters (P0/P1) with intron-4 elements were shown to drive tissue-specific expression, and the homeodomain was shown to bind TBP and Rb.","evidence":"Transgenic promoter-deletion reporter assays; GST pull-downs and immunoprecipitation from lens nuclear extracts","pmids":["9847251","10359315"],"confidence":"Medium","gaps":["Functional consequence of the Rb interaction not established","TBP interaction not validated in vivo"]},{"year":2000,"claim":"Explaining dosage sensitivity mechanistically: a critical PAX6 protein threshold was shown necessary for lens placode formation, with heterozygosity causing delayed placode formation, N-cadherin failure, and apoptosis—shown not to result from monoallelic expression.","evidence":"Histology, cell counting, apoptosis assays, and allele-specific expression analysis in heterozygous Sey mouse embryos","pmids":["11076764"],"confidence":"High","gaps":["Direct PAX6 regulation of N-cadherin not demonstrated","Threshold mechanism at the molecular level unresolved"]},{"year":2001,"claim":"Dissecting the contribution of each DNA-binding module: missense mutations showed that Q422R selectively abolishes homeodomain DNA binding and P375Q disrupts paired-domain binding, establishing that both domains and the C-terminal residue are required for full function.","evidence":"Site-directed mutagenesis, EMSA, and transfection reporter assays in multiple cell lines","pmids":["11309364","14744876"],"confidence":"High","gaps":["Did not map full target-gene repertoire dependent on each domain","In vivo consequences of isolated domain loss not tested"]},{"year":2002,"claim":"Placing PAX6 in cross-regulatory networks: mutual activation with Six3 in the lens (and mutual repression with Emx2 in cortex) revealed feedback loops, and Six3-driven rescue of haploinsufficiency activated the PDGF-alpha-R/cyclin D1 proliferative pathway.","evidence":"EMSA, transgenic reporter assays, Pax6+/- rescue transgenics, and loss-of-function marker analysis","pmids":["12072567","11739261"],"confidence":"High","gaps":["Direct binding sites in Six3/Emx2 regulatory regions only partially defined","Hierarchy among feedback loops in vivo unclear"]},{"year":2005,"claim":"Demonstrating direct target gene activation: PAX6 was shown to bind the Optimedin promoter through its paired domain in vivo and activate transcription, providing a defined direct target with binding-site validation.","evidence":"EMSA, site-directed mutagenesis, luciferase reporter, and ChIP","pmids":["16115881"],"confidence":"High","gaps":["Functional role of Optimedin downstream of PAX6 not established","Generalizability of paired-domain binding to other targets not shown here"]},{"year":2006,"claim":"Identifying post-translational and upstream control of activity: HIPK2 phosphorylation at T281/T304/T373 promotes p300 interaction and transactivation, Six3 directly activates Pax6 at the top of the lens pathway, and a Meis-Pbx enhancer controls pancreatic Pax6 expression.","evidence":"Mass spectrometry, mutagenesis, shRNA, co-IP, ChIP/EMSA, conditional and knockout mouse models, and transgenic enhancer assays","pmids":["16407227","17066077","17049510"],"confidence":"High","gaps":["Whether phosphorylation occurs in all PAX6-expressing tissues unknown","Integration of upstream activators with phosphorylation not addressed"]},{"year":2009,"claim":"Establishing roles in differentiation, proliferation, and tissue homeostasis: conditional knockout showed PAX6 is required for lens fiber differentiation and cell-cycle exit (via Sfrp2), morpholino knockdown showed it drives proliferation in lens regeneration, and heterozygosity produced a chronic-wound-like corneal phenotype.","evidence":"Cre/loxP conditional knockout, newt morpholino knockdown with BrdU assays, and corneal histology/MAPK analysis in Pax6+/- mice","pmids":["19570848","17003134","19933176"],"confidence":"Medium","gaps":["Direct vs indirect regulation of Sfrp2 incompletely resolved","Single-lab observations for regeneration and corneal phenotypes"]},{"year":2010,"claim":"Resolving isoform-specific function in human cell-fate decisions: PAX6a (not PAX6b or PAX6deltaPD) was shown sufficient to convert hESCs to neuroectoderm, with PAX6a binding NE gene promoters while PAX6b binds pluripotency genes.","evidence":"hESC differentiation, isoform overexpression and knockdown, and ChIP-based promoter binding analysis","pmids":["20621053"],"confidence":"High","gaps":["Structural basis for isoform-specific target selection not defined","Cofactors distinguishing isoform binding not identified"]},{"year":2016,"claim":"Defining genome-wide target logic and adult identity maintenance: ChIP-seq revealed PAX6 co-occupies promoters with Sox2 to activate neural and repress non-neural genes (including direct activation of Ift74), and conditional deletion showed PAX6 maintains adult beta-cell identity by repressing alternative islet genes.","evidence":"ChIP-seq, transcriptome analysis, in utero knockdown, conditional beta-cell deletion with lineage tracing, and human islet shRNA","pmids":["27462442","27941241","27818314"],"confidence":"High","gaps":["Mechanism of repression vs activation at co-occupied loci unresolved","How cofactor context switches PAX6 between activation and repression unknown"]},{"year":2021,"claim":"Adding chromatin-modifying and disease-context mechanisms: PAX6 recruits NSD1 via its C-terminal PST domain (with lncRNA PAUPAR) to deposit H3K36 methylation at neural targets, and in Alzheimer's brains PAX6 directly drives GSK-3beta transcription to promote tau hyperphosphorylation.","evidence":"hESC/organoid differentiation with PAUPAR knockdown, co-IP and ChIP; AD brain and APP transgenic analysis with ChIP and tau phosphorylation assays","pmids":["33544864","34428276"],"confidence":"Medium","gaps":["NSD1/PAUPAR mechanism resolved by single-lab co-IP and ChIP","Causality of PAX6 in human AD pathology not established beyond correlation and knockdown"]},{"year":null,"claim":"How PAX6 context-dependently switches between gene activation and repression at co-occupied loci, and how its dosage, isoform usage, phosphorylation, and chromatin-cofactor recruitment are integrated across distinct tissues, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking domain-specific binding to activation vs repression outcomes","Tissue-specific cofactor maps incomplete","Structural basis of isoform-selective targeting not determined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[16,17,18,26,30,31]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[16,17,18,26,30,31]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[7,18,30]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[3,8,11,28]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[18,26,30,31]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[34]}],"complexes":[],"partners":["HIPK2","EP300","TBP","RB1","SIX3","SOX2","NSD1","PAUPAR"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P26367","full_name":"Paired box protein Pax-6","aliases":["Aniridia type II protein","Oculorhombin"],"length_aa":422,"mass_kda":46.7,"function":"Transcription factor with important functions in the development of the eye, nose, central nervous system and pancreas. Required for the differentiation of pancreatic islet alpha cells (By similarity). Competes with PAX4 in binding to a common element in the glucagon, insulin and somatostatin promoters. Regulates specification of the ventral neuron subtypes by establishing the correct progenitor domains (By similarity). Acts as a transcriptional repressor of NFATC1-mediated gene expression (By similarity)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/P26367/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PAX6","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1208,"dependency_fraction":0.0024834437086092716},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PAX6","total_profiled":1310},"omim":[{"mim_id":"621283","title":"COILED-COIL DOMAIN-CONTAINING PROTEIN 85C; CCDC85C","url":"https://www.omim.org/entry/621283"},{"mim_id":"619820","title":"ATONAL bHLH TRANSCRIPTION FACTOR 8; ATOH8","url":"https://www.omim.org/entry/619820"},{"mim_id":"619583","title":"EH DOMAIN-BINDING PROTEIN 1-LIKE 1; EHBP1L1","url":"https://www.omim.org/entry/619583"},{"mim_id":"619560","title":"MICRO RNA 135B; MIR135B","url":"https://www.omim.org/entry/619560"},{"mim_id":"618646","title":"DIENCEPHALIC-MESENCEPHALIC JUNCTION DYSPLASIA SYNDROME 2; DMJDS2","url":"https://www.omim.org/entry/618646"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoplasm","reliability":"Enhanced"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":80.4},{"tissue":"retina","ntpm":63.9}],"url":"https://www.proteinatlas.org/search/PAX6"},"hgnc":{"alias_symbol":["D11S812E","AN","WAGR"],"prev_symbol":["AN1","AN2"]},"alphafold":{"accession":"P26367","domains":[{"cath_id":"1.10.10.10","chopping":"5-62","consensus_level":"high","plddt":96.2291,"start":5,"end":62},{"cath_id":"1.10.10.10","chopping":"80-142","consensus_level":"high","plddt":89.574,"start":80,"end":142},{"cath_id":"1.10.10.60","chopping":"218-275","consensus_level":"high","plddt":93.4319,"start":218,"end":275}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P26367","model_url":"https://alphafold.ebi.ac.uk/files/AF-P26367-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P26367-F1-predicted_aligned_error_v6.png","plddt_mean":68.44},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PAX6","jax_strain_url":"https://www.jax.org/strain/search?query=PAX6"},"sequence":{"accession":"P26367","fasta_url":"https://rest.uniprot.org/uniprotkb/P26367.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P26367/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P26367"}},"corpus_meta":[{"pmid":"1345175","id":"PMC_1345175","title":"Genomic structure, evolutionary conservation and aniridia mutations in the human PAX6 gene.","date":"1992","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/1345175","citation_count":574,"is_preprint":false},{"pmid":"20621053","id":"PMC_20621053","title":"Pax6 is a human neuroectoderm cell fate determinant.","date":"2010","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/20621053","citation_count":377,"is_preprint":false},{"pmid":"9056723","id":"PMC_9056723","title":"PAX-6 in development and evolution.","date":"1997","source":"Annual review of neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/9056723","citation_count":368,"is_preprint":false},{"pmid":"7696880","id":"PMC_7696880","title":"Cloning and characterization of the maize An1 gene.","date":"1995","source":"The Plant cell","url":"https://pubmed.ncbi.nlm.nih.gov/7696880","citation_count":332,"is_preprint":false},{"pmid":"12386935","id":"PMC_12386935","title":"Pax6; a pleiotropic player in development.","date":"2002","source":"BioEssays : news and reviews in molecular, cellular and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/12386935","citation_count":257,"is_preprint":false},{"pmid":"10409504","id":"PMC_10409504","title":"Role of Pax6 in development of the cerebellar system.","date":"1999","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10409504","citation_count":250,"is_preprint":false},{"pmid":"15080895","id":"PMC_15080895","title":"Regionalization and fate specification in neurospheres: the role of Olig2 and Pax6.","date":"2004","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/15080895","citation_count":226,"is_preprint":false},{"pmid":"25030175","id":"PMC_25030175","title":"WNT7A and PAX6 define corneal epithelium homeostasis and pathogenesis.","date":"2014","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/25030175","citation_count":201,"is_preprint":false},{"pmid":"9482572","id":"PMC_9482572","title":"PAX6 mutations reviewed.","date":"1998","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/9482572","citation_count":200,"is_preprint":false},{"pmid":"8600027","id":"PMC_8600027","title":"Multiple functions for Pax6 in mouse eye and nasal development.","date":"1996","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/8600027","citation_count":197,"is_preprint":false},{"pmid":"22561546","id":"PMC_22561546","title":"Pax6: a multi-level regulator of ocular development.","date":"2012","source":"Progress in retinal and eye research","url":"https://pubmed.ncbi.nlm.nih.gov/22561546","citation_count":192,"is_preprint":false},{"pmid":"11698186","id":"PMC_11698186","title":"Pax6 lights-up the way for eye development.","date":"2001","source":"Current opinion in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11698186","citation_count":185,"is_preprint":false},{"pmid":"12015275","id":"PMC_12015275","title":"PAX6 in sensory development.","date":"2002","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12015275","citation_count":184,"is_preprint":false},{"pmid":"15918896","id":"PMC_15918896","title":"PAX6 mutations: genotype-phenotype correlations.","date":"2005","source":"BMC genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15918896","citation_count":174,"is_preprint":false},{"pmid":"20118109","id":"PMC_20118109","title":"Two R2R3-MYB genes, homologs of Petunia AN2, regulate anthocyanin biosyntheses in flower Tepals, tepal spots and leaves of asiatic hybrid lily.","date":"2010","source":"Plant & cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/20118109","citation_count":158,"is_preprint":false},{"pmid":"8364574","id":"PMC_8364574","title":"PAX6 mutations in aniridia.","date":"1993","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8364574","citation_count":154,"is_preprint":false},{"pmid":"9847251","id":"PMC_9847251","title":"Regulation of Pax6 expression is conserved between mice and flies.","date":"1999","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9847251","citation_count":152,"is_preprint":false},{"pmid":"14762144","id":"PMC_14762144","title":"Pax6 and engrailed 1 regulate two distinct aspects of renshaw cell development.","date":"2004","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/14762144","citation_count":148,"is_preprint":false},{"pmid":"21538923","id":"PMC_21538923","title":"The role of Pax6 in forebrain development.","date":"2011","source":"Developmental neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/21538923","citation_count":147,"is_preprint":false},{"pmid":"31861090","id":"PMC_31861090","title":"The Spectrum of PAX6 Mutations and Genotype-Phenotype Correlations in the Eye.","date":"2019","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/31861090","citation_count":140,"is_preprint":false},{"pmid":"17066077","id":"PMC_17066077","title":"Six3 activation of Pax6 expression is essential for mammalian lens induction and specification.","date":"2006","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/17066077","citation_count":139,"is_preprint":false},{"pmid":"11739261","id":"PMC_11739261","title":"Emx2 and Pax6 control regionalization of the pre-neuronogenic cortical primordium.","date":"2002","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/11739261","citation_count":136,"is_preprint":false},{"pmid":"27941241","id":"PMC_27941241","title":"PAX6 maintains β cell identity by repressing genes of alternative islet cell types.","date":"2016","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/27941241","citation_count":129,"is_preprint":false},{"pmid":"11756345","id":"PMC_11756345","title":"PAX6 mutation as a genetic factor common to aniridia and glucose intolerance.","date":"2002","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/11756345","citation_count":121,"is_preprint":false},{"pmid":"7668281","id":"PMC_7668281","title":"Mutation of the PAX6 gene in patients with autosomal dominant keratitis.","date":"1995","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/7668281","citation_count":118,"is_preprint":false},{"pmid":"11329183","id":"PMC_11329183","title":"AN2/NG2 protein-expressing glial progenitor cells in the murine CNS: isolation, differentiation, and association with radial glia.","date":"2001","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/11329183","citation_count":111,"is_preprint":false},{"pmid":"10572034","id":"PMC_10572034","title":"The role of Pax6 in restricting cell migration between developing cortex and basal ganglia.","date":"1999","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10572034","citation_count":110,"is_preprint":false},{"pmid":"27126352","id":"PMC_27126352","title":"PAX6: 25th anniversary and more to learn.","date":"2016","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/27126352","citation_count":108,"is_preprint":false},{"pmid":"16307364","id":"PMC_16307364","title":"The maize An2 gene is induced by Fusarium attack and encodes an ent-copalyl diphosphate synthase.","date":"2005","source":"Plant molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/16307364","citation_count":107,"is_preprint":false},{"pmid":"1697675","id":"PMC_1697675","title":"Targeted degradation of mRNA in Xenopus oocytes and embryos directed by modified oligonucleotides: studies of An2 and cyclin in embryogenesis.","date":"1990","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/1697675","citation_count":107,"is_preprint":false},{"pmid":"19570848","id":"PMC_19570848","title":"Pax6 is essential for lens fiber cell differentiation.","date":"2009","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/19570848","citation_count":107,"is_preprint":false},{"pmid":"20852734","id":"PMC_20852734","title":"Expression of pax6 and sox2 in adult olfactory epithelium.","date":"2010","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/20852734","citation_count":104,"is_preprint":false},{"pmid":"11076764","id":"PMC_11076764","title":"Dosage requirement and allelic expression of PAX6 during lens placode formation.","date":"2000","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11076764","citation_count":95,"is_preprint":false},{"pmid":"11688562","id":"PMC_11688562","title":"Pax6 regulates granule cell polarization during parallel fiber formation in the developing cerebellum.","date":"2001","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11688562","citation_count":93,"is_preprint":false},{"pmid":"27462442","id":"PMC_27462442","title":"Mapping gene regulatory circuitry of Pax6 during neurogenesis.","date":"2016","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/27462442","citation_count":92,"is_preprint":false},{"pmid":"15901670","id":"PMC_15901670","title":"PAX6 expression identifies progenitor cells for corneal keratocytes.","date":"2005","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/15901670","citation_count":88,"is_preprint":false},{"pmid":"10340984","id":"PMC_10340984","title":"PAX6 expression in the developing human eye.","date":"1999","source":"The British journal of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/10340984","citation_count":87,"is_preprint":false},{"pmid":"10766016","id":"PMC_10766016","title":"Regulation of eye formation by the Rx and pax6 homeobox genes.","date":"2000","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/10766016","citation_count":83,"is_preprint":false},{"pmid":"10354469","id":"PMC_10354469","title":"Pax2/5 and Pax6 subdivide the early neural tube into three domains.","date":"1999","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/10354469","citation_count":83,"is_preprint":false},{"pmid":"12764040","id":"PMC_12764040","title":"Emx1, emx2 and pax6 in specification, regionalization and arealization of the cerebral cortex.","date":"2003","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/12764040","citation_count":81,"is_preprint":false},{"pmid":"9399848","id":"PMC_9399848","title":"The Human PAX6 Mutation Database.","date":"1998","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/9399848","citation_count":74,"is_preprint":false},{"pmid":"12072567","id":"PMC_12072567","title":"Mutually regulated expression of Pax6 and Six3 and its implications for the Pax6 haploinsufficient lens phenotype.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12072567","citation_count":73,"is_preprint":false},{"pmid":"10861471","id":"PMC_10861471","title":"PAX6 methylation and ectopic expression in human tumor cells.","date":"2000","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/10861471","citation_count":68,"is_preprint":false},{"pmid":"16407227","id":"PMC_16407227","title":"Phosphorylation and transactivation of Pax6 by homeodomain-interacting protein kinase 2.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16407227","citation_count":68,"is_preprint":false},{"pmid":"11455425","id":"PMC_11455425","title":"Early and late changes in Pax6 expression accompany eye degeneration during cavefish development.","date":"2001","source":"Development genes and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/11455425","citation_count":64,"is_preprint":false},{"pmid":"14561779","id":"PMC_14561779","title":"PAX6 and congenital eye malformations.","date":"2003","source":"Pediatric research","url":"https://pubmed.ncbi.nlm.nih.gov/14561779","citation_count":58,"is_preprint":false},{"pmid":"25159050","id":"PMC_25159050","title":"High AN1 variability and interaction with basic helix-loop-helix co-factors related to anthocyanin biosynthesis in potato leaves.","date":"2014","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/25159050","citation_count":58,"is_preprint":false},{"pmid":"27818314","id":"PMC_27818314","title":"PAX6 regulates human corneal epithelium cell identity.","date":"2016","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/27818314","citation_count":57,"is_preprint":false},{"pmid":"27081561","id":"PMC_27081561","title":"Genotype-phenotype correlation of PAX6 gene mutations in aniridia.","date":"2016","source":"Human genome variation","url":"https://pubmed.ncbi.nlm.nih.gov/27081561","citation_count":57,"is_preprint":false},{"pmid":"17049510","id":"PMC_17049510","title":"Pax6 is regulated by Meis and Pbx homeoproteins during pancreatic development.","date":"2006","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/17049510","citation_count":57,"is_preprint":false},{"pmid":"27124303","id":"PMC_27124303","title":"Genetic Analysis of 'PAX6-Negative' Individuals with Aniridia or Gillespie Syndrome.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27124303","citation_count":55,"is_preprint":false},{"pmid":"11157078","id":"PMC_11157078","title":"The AN2 protein is a novel marker for the Schwann cell lineage expressed by immature and nonmyelinating Schwann cells.","date":"2001","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/11157078","citation_count":54,"is_preprint":false},{"pmid":"17524611","id":"PMC_17524611","title":"Phylogenetic and expression analysis of ZnF-AN1 genes in plants.","date":"2007","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/17524611","citation_count":54,"is_preprint":false},{"pmid":"12618140","id":"PMC_12618140","title":"Pax6 regulates regional development and neuronal migration in the cerebral cortex.","date":"2003","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/12618140","citation_count":53,"is_preprint":false},{"pmid":"18786519","id":"PMC_18786519","title":"Spatio-temporal expression of Pax6 in Xenopus forebrain.","date":"2008","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/18786519","citation_count":53,"is_preprint":false},{"pmid":"10610023","id":"PMC_10610023","title":"Expression pattern of PAX3 and PAX6 genes during human embryogenesis.","date":"1999","source":"The International journal of developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/10610023","citation_count":52,"is_preprint":false},{"pmid":"17003134","id":"PMC_17003134","title":"The role of Pax-6 in lens regeneration.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17003134","citation_count":52,"is_preprint":false},{"pmid":"16024294","id":"PMC_16024294","title":"Pax6-dependence of Six3, Eya1 and Dach1 expression during lens and nasal placode induction.","date":"2005","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/16024294","citation_count":51,"is_preprint":false},{"pmid":"19862335","id":"PMC_19862335","title":"PAX6 aniridia and interhemispheric brain anomalies.","date":"2009","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/19862335","citation_count":51,"is_preprint":false},{"pmid":"14744876","id":"PMC_14744876","title":"Functional properties of natural human PAX6 and PAX6(5a) mutants.","date":"2004","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/14744876","citation_count":50,"is_preprint":false},{"pmid":"21316795","id":"PMC_21316795","title":"OsDOG, a gibberellin-induced A20/AN1 zinc-finger protein, negatively regulates gibberellin-mediated cell elongation in rice.","date":"2011","source":"Journal of plant physiology","url":"https://pubmed.ncbi.nlm.nih.gov/21316795","citation_count":50,"is_preprint":false},{"pmid":"10359315","id":"PMC_10359315","title":"Pax-6 interactions with TATA-box-binding protein and retinoblastoma protein.","date":"1999","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/10359315","citation_count":49,"is_preprint":false},{"pmid":"11309364","id":"PMC_11309364","title":"Missense mutation at the C-terminus of PAX6 negatively modulates homeodomain function.","date":"2001","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11309364","citation_count":49,"is_preprint":false},{"pmid":"17509554","id":"PMC_17509554","title":"Mechanisms controlling Pax6 isoform expression in the retina have been conserved between teleosts and mammals.","date":"2007","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/17509554","citation_count":47,"is_preprint":false},{"pmid":"27581449","id":"PMC_27581449","title":"A Novel and Multivalent Role of Pax6 in Cerebellar Development.","date":"2016","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/27581449","citation_count":46,"is_preprint":false},{"pmid":"15452066","id":"PMC_15452066","title":"Ectopic Pax6 expression disturbs lens fiber cell differentiation.","date":"2004","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/15452066","citation_count":45,"is_preprint":false},{"pmid":"2347591","id":"PMC_2347591","title":"Location of the gene involving the small eye mutation on mouse chromosome 2 suggests homology with human aniridia 2 (AN2).","date":"1990","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/2347591","citation_count":45,"is_preprint":false},{"pmid":"14501219","id":"PMC_14501219","title":"AN2, the mouse homologue of NG2, is a surface antigen on glial precursor cells implicated in control of cell migration.","date":"2002","source":"Journal of neurocytology","url":"https://pubmed.ncbi.nlm.nih.gov/14501219","citation_count":44,"is_preprint":false},{"pmid":"10737978","id":"PMC_10737978","title":"Mutation in the PAX6 gene in twenty patients with aniridia.","date":"2000","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/10737978","citation_count":43,"is_preprint":false},{"pmid":"34428276","id":"PMC_34428276","title":"Amyloid-β toxicity modulates tau phosphorylation through the PAX6 signalling pathway.","date":"2021","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/34428276","citation_count":41,"is_preprint":false},{"pmid":"21617155","id":"PMC_21617155","title":"Discovery and assessment of conserved Pax6 target genes and enhancers.","date":"2011","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/21617155","citation_count":40,"is_preprint":false},{"pmid":"27470361","id":"PMC_27470361","title":"MiR-433 inhibits retinoblastoma malignancy by suppressing Notch1 and PAX6 expression.","date":"2016","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/27470361","citation_count":39,"is_preprint":false},{"pmid":"12764036","id":"PMC_12764036","title":"Pax6 regulates cell adhesion during cortical development.","date":"2003","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/12764036","citation_count":38,"is_preprint":false},{"pmid":"25794677","id":"PMC_25794677","title":"Onecut1 and Onecut2 transcription factors operate downstream of Pax6 to regulate horizontal cell development.","date":"2015","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/25794677","citation_count":36,"is_preprint":false},{"pmid":"30291432","id":"PMC_30291432","title":"Implication of non-coding PAX6 mutations in aniridia.","date":"2018","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30291432","citation_count":35,"is_preprint":false},{"pmid":"27171428","id":"PMC_27171428","title":"Sox2 and Pax6 Play Counteracting Roles in Regulating Neurogenesis within the Murine Olfactory Epithelium.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27171428","citation_count":35,"is_preprint":false},{"pmid":"32396632","id":"PMC_32396632","title":"PAX6 Genotypic and Retinal Phenotypic Characterization in Congenital Aniridia.","date":"2020","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/32396632","citation_count":34,"is_preprint":false},{"pmid":"1505982","id":"PMC_1505982","title":"Resolution of the two loci for autosomal dominant aniridia, AN1 and AN2, to a single locus on chromosome 11p13.","date":"1992","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/1505982","citation_count":34,"is_preprint":false},{"pmid":"24637479","id":"PMC_24637479","title":"PAX6 gene associated with high myopia: a meta-analysis.","date":"2014","source":"Optometry and vision science : official publication of the American Academy of Optometry","url":"https://pubmed.ncbi.nlm.nih.gov/24637479","citation_count":33,"is_preprint":false},{"pmid":"19933176","id":"PMC_19933176","title":"Cytoskeletal and cell adhesion defects in wounded and Pax6+/- corneal epithelia.","date":"2009","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/19933176","citation_count":32,"is_preprint":false},{"pmid":"33311477","id":"PMC_33311477","title":"AN1-type zinc finger protein 3 (ZFAND3) is a transcriptional regulator that drives Glioblastoma invasion.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33311477","citation_count":29,"is_preprint":false},{"pmid":"15523634","id":"PMC_15523634","title":"Differential expression of Pax6 and Ngn2 between pair-generated cortical neurons.","date":"2004","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/15523634","citation_count":29,"is_preprint":false},{"pmid":"34101622","id":"PMC_34101622","title":"Longitudinal genotype-phenotype analysis in 86 patients with PAX6-related aniridia.","date":"2021","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/34101622","citation_count":29,"is_preprint":false},{"pmid":"31035916","id":"PMC_31035916","title":"Functional MYB transcription factor encoding gene AN2 is associated with anthocyanin biosynthesis in Lycium ruthenicum Murray.","date":"2019","source":"BMC plant biology","url":"https://pubmed.ncbi.nlm.nih.gov/31035916","citation_count":28,"is_preprint":false},{"pmid":"16115881","id":"PMC_16115881","title":"The Optimedin gene is a downstream target of Pax6.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16115881","citation_count":28,"is_preprint":false},{"pmid":"12175506","id":"PMC_12175506","title":"Differential Pax6 promoter activity and transcript expression during forebrain development.","date":"2002","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/12175506","citation_count":28,"is_preprint":false},{"pmid":"19223471","id":"PMC_19223471","title":"Pax6 regulates the proglucagon processing enzyme PC2 and its chaperone 7B2.","date":"2009","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19223471","citation_count":28,"is_preprint":false},{"pmid":"25089088","id":"PMC_25089088","title":"Regulation of Human PAX6 Expression by miR-7.","date":"2014","source":"Evolutionary bioinformatics online","url":"https://pubmed.ncbi.nlm.nih.gov/25089088","citation_count":27,"is_preprint":false},{"pmid":"19683074","id":"PMC_19683074","title":"Shh and Pax6 have unconventional expression patterns in embryonic morphogenesis in Sepia officinalis (Cephalopoda).","date":"2009","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/19683074","citation_count":27,"is_preprint":false},{"pmid":"23578930","id":"PMC_23578930","title":"A novel role for Pax6 in the segmental organization of the hindbrain.","date":"2013","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/23578930","citation_count":27,"is_preprint":false},{"pmid":"33298563","id":"PMC_33298563","title":"Gene dosage manipulation alleviates manifestations of hereditary PAX6 haploinsufficiency in mice.","date":"2020","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33298563","citation_count":26,"is_preprint":false},{"pmid":"21169528","id":"PMC_21169528","title":"Pax6 regulates proliferation and apoptosis of human retinoblastoma cells.","date":"2011","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/21169528","citation_count":26,"is_preprint":false},{"pmid":"30212572","id":"PMC_30212572","title":"Plant A20/AN1 protein serves as the important hub to mediate antiviral immunity.","date":"2018","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/30212572","citation_count":25,"is_preprint":false},{"pmid":"32467297","id":"PMC_32467297","title":"Analysis of genotype-phenotype correlations in PAX6-associated aniridia.","date":"2020","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/32467297","citation_count":25,"is_preprint":false},{"pmid":"33544864","id":"PMC_33544864","title":"PAUPAR and PAX6 sequentially regulate human embryonic stem cell cortical differentiation.","date":"2021","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/33544864","citation_count":24,"is_preprint":false},{"pmid":"29980566","id":"PMC_29980566","title":"Eyeless/Pax6 initiates eye formation non-autonomously from the peripodial epithelium.","date":"2018","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/29980566","citation_count":24,"is_preprint":false},{"pmid":"21922321","id":"PMC_21922321","title":"A common variant upstream of the PAX6 gene influences islet function in man.","date":"2011","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/21922321","citation_count":24,"is_preprint":false},{"pmid":"29436400","id":"PMC_29436400","title":"Association of the PAX6 gene with extreme myopia rather than lower grade myopias.","date":"2018","source":"The British journal of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/29436400","citation_count":23,"is_preprint":false},{"pmid":"21296585","id":"PMC_21296585","title":"A stress-associated protein containing A20/AN1 zing-finger domains expressed in Medicago truncatula seeds.","date":"2011","source":"Plant physiology and biochemistry : PPB","url":"https://pubmed.ncbi.nlm.nih.gov/21296585","citation_count":23,"is_preprint":false},{"pmid":"26525840","id":"PMC_26525840","title":"Pax6 influences expression patterns of genes involved in neuro- degeneration.","date":"2015","source":"Annals of neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/26525840","citation_count":23,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":45921,"output_tokens":8198,"usd":0.130366,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17924,"output_tokens":4817,"usd":0.105023,"stage2_stop_reason":"end_turn"},"total_usd":0.235389,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1992,\n      \"finding\": \"PAX6 spans 22 kilobases and is divided into 14 exons; intragenic mutations (including nonsense and frameshift) in PAX6 cause human aniridia, establishing that aniridia results from loss-of-function of the PAX6 gene.\",\n      \"method\": \"cDNA cloning, intron-exon mapping, direct sequencing of aniridia patient DNA\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genomic structure determined by cloning, mutations confirmed by sequencing in multiple independent patients, replicated across labs\",\n      \"pmids\": [\"1345175\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"Chromosomal mapping placed the mouse Small eye (Sey) gene on chromosome 2 in a region syntenic with human chromosome 11p13, where the aniridia locus AN2 resides, establishing that Sey is the mouse homolog of human PAX6/AN2.\",\n      \"method\": \"Interspecific backcross linkage mapping\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic mapping with multiple markers, single study, later confirmed by mutation identification\",\n      \"pmids\": [\"2347591\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"The originally proposed AN1 locus on chromosome 2p for autosomal dominant aniridia was shown by linkage analysis to be misassigned; all aniridia maps to a single locus at 11p13 corresponding to PAX6/AN2.\",\n      \"method\": \"Linkage analysis with chromosome 2p and 11p13 markers in expanded aniridia kindred\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — rigorous linkage analysis excluding 2p and confirming 11p13, replicated across multiple families\",\n      \"pmids\": [\"1505982\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Pax6 acts cell-autonomously in the optic cup and controls the fate of surface ectoderm giving rise to lens and nasal epithelium; Pax6-mutant cells were excluded from the lens, nasal epithelium, and retinal pigmented epithelium in chimeric embryos, and did not intermix normally in other retinal regions.\",\n      \"method\": \"Chimeric mouse embryo analysis (wild-type + Sey mutant cells)\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct chimera experiments demonstrating cell-autonomous function, replicated across multiple chimeras\",\n      \"pmids\": [\"8600027\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Pax6 is required for cell migration and neurite extension of rhombic lip-derived neurons; Pax6-null embryos show disruption of three of five precerebellar nuclei and absence of granule cell pre-migratory sub-layer, associated with complete loss of Unc5h3 (netrin receptor) expression, placing Pax6 upstream of Unc5h3 in hindbrain migration.\",\n      \"method\": \"Analysis of Pax6(Sey/Sey) null mouse embryos; in situ hybridization for Unc5h3\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic loss-of-function with defined cellular and molecular phenotype, downstream target identified\",\n      \"pmids\": [\"10409504\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Pax6 restricts ventro-dorsal cell migration in the developing telencephalon; loss of Pax6 strongly enhances invasion of cortex by cells from the ganglionic eminence, demonstrating Pax6 functions to maintain the cortico-striatal boundary.\",\n      \"method\": \"Adenoviral GFP focal injection to track cell migration in wild-type vs. Pax6 mutant (Small Eye) mouse telencephalon\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct cell-tracking experiment in vivo in null mutant, quantified cell migration with clear phenotypic readout\",\n      \"pmids\": [\"10572034\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Pax6 is regulated by two distinct promoters (P0 and P1) that direct differential expression in the developing eye; P0-initiated transcripts predominate in lens placode and corneal/conjunctival epithelia, while P1-initiated transcripts are expressed in lens placode, optic vesicle, and CNS. Multiple cis-acting elements (including one in intron 4) combinatorially control tissue-specific expression.\",\n      \"method\": \"Transgenic mouse reporter assays with promoter-deletion constructs\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — functional dissection using multiple transgenic lines, two independent promoters mapped with defined regulatory elements\",\n      \"pmids\": [\"9847251\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Pax6 homeodomain (HD) physically interacts with TATA-box-binding protein (TBP), mediated by the N-terminal arm and first two alpha-helices of the HD plus the C-terminal activation domain; Pax6 HD also interacts with retinoblastoma protein (Rb), and Pax6/Rb complexes were detected in lens nuclear extracts.\",\n      \"method\": \"Affinity chromatography, GST pull-down assays, immunoprecipitation from lens nuclear extracts\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal pull-downs and immunoprecipitation, single lab, multiple binding assays\",\n      \"pmids\": [\"10359315\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"A critical threshold of PAX6 protein is required for lens placode formation; heterozygous Pax6 mutation causes a delay in lens placode formation, failure of N-cadherin expression at the lens cup edge, and apoptosis, not due to monoallelic expression (shown to be biallelic by allelic expression analysis).\",\n      \"method\": \"Analysis of Pax6(Sey-1Neu)/+ heterozygous embryos; cell counting, mitotic index, apoptosis assays, allele-specific expression analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (histology, cell counts, apoptosis, allelic expression), mechanistic conclusion about dosage threshold\",\n      \"pmids\": [\"11076764\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Pax6 controls cytoskeletal organization and polarity of cerebellar granule cells; Pax6 mutant rat granule cells fail to form parallel fiber axons and migrate tangentially, sprouting multiple neurites with enlarged growth cones. This effect is cell-autonomous and rescuable by ectopic Pax6 expression, and is independent of ROCK-mediated Rho GTPase signaling.\",\n      \"method\": \"Analysis of Pax6 mutant rats (rSey2/rSey2); granule cell culture; rescue by ectopic Pax6 expression; ROCK pathway inhibition\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function phenotype with cell-autonomous rescue and pathway exclusion, multiple methods\",\n      \"pmids\": [\"11688562\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Pax6 and Emx2 mutually down-regulate each other's expression in the developing cortex; loss of Emx2 or Pax6 reduces their respective cortical regions and impairs WNT signaling center at the medial-caudal cortical edge.\",\n      \"method\": \"Analysis of Emx2 and Pax6 loss-of-function mouse mutants; molecular marker expression\",\n      \"journal\": \"Cerebral cortex (New York, N.Y. : 1991)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function, multiple molecular markers, single lab\",\n      \"pmids\": [\"11739261\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Six3 and Pax6 mutually activate each other's expression in the developing lens: Six3 binds regulatory sequences of Pax6 and Pax6 binds regulatory sequences of Six3 (in vitro and transgenic approaches). Rescue of the Pax6 haploinsufficient lens phenotype by lens-specific Six3 overexpression activates the PDGF-alpha-R/cyclin D1 proliferative pathway.\",\n      \"method\": \"In vitro binding assays (EMSA), transgenic mouse reporter assays, Pax6+/- rescue transgenic mice\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — EMSA plus transgenic functional rescue, multiple orthogonal methods, mechanistic pathway identified\",\n      \"pmids\": [\"12072567\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Pax6 regulates cell adhesion in the developing cerebral cortex in a cell-autonomous manner; Pax6-deficient cortical cells segregate from wild-type cells and form dense clusters after transplantation into wild-type cortex, and show enhanced clustering in explant migration assays.\",\n      \"method\": \"Cell transplants into wild-type embryonic cortex; explant migration assays with Pax6(Sey/Sey) cells\",\n      \"journal\": \"Cerebral cortex (New York, N.Y. : 1991)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — cell-autonomous demonstration via transplantation and explant culture, single lab\",\n      \"pmids\": [\"12764036\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Pax6 regulates radial migration of neuronal precursors, specifically affecting movement at the subventricular zone/intermediate zone boundary; chimera analysis shows Pax6-deficient cells are specifically reduced in the mediocaudal cortical domain, indicating a role in regionalization alongside migration.\",\n      \"method\": \"Mouse chimera analysis (wild-type + Pax6-deficient cells); BrdU labeling and cell distribution analysis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — chimera analysis with specific migration phenotype, single lab\",\n      \"pmids\": [\"12618140\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Pax6 is genetically upstream of En1 (Engrailed 1) in Renshaw cell development; Pax6 is required for an early step in Renshaw cell specification, while En1 (downstream of Pax6) regulates inhibitory synapse formation between Renshaw cells and motor neurons.\",\n      \"method\": \"Analysis of Pax6 and En1 mutant mice; genetic epistasis; immunohistochemistry\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis established by double-mutant analysis, single lab\",\n      \"pmids\": [\"14762144\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Sustained ectopic Pax6 expression in lens fiber cells disrupts differentiation: it reduces cMaf protein levels and dramatically decreases betaB1-crystallin expression, demonstrating that downregulation of Pax6 is required for normal fiber cell differentiation and that Pax6 negatively regulates cMaf.\",\n      \"method\": \"Transgenic mice with alphaA-crystallin promoter-driven Pax6; 2D gel electrophoresis, immunohistochemistry, RT-PCR, in situ hybridization\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — gain-of-function transgenic mice with multiple orthogonal readouts identifying downstream target (cMaf)\",\n      \"pmids\": [\"15452066\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"PAX6 and PAX6(5a) transactivation is modulated by specific cellular environments and the location/type of missense mutation; DNA binding by PAX6 homeodomain is required for full function, and a C-terminal missense mutation (Q422R) abolishes homeodomain DNA binding.\",\n      \"method\": \"Site-directed mutagenesis, transfection reporter assays in four cell lines, EMSA\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro mutagenesis combined with DNA-binding assays and transactivation in multiple cell lines, single lab\",\n      \"pmids\": [\"14744876\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Missense mutation Q422R at the C-terminus of PAX6 specifically abolishes homeodomain DNA binding of intact PAX6, demonstrating that the C-terminal amino acid modulates homeodomain function; paired domain DNA binding is separately disrupted by the P375Q mutation.\",\n      \"method\": \"Site-directed mutagenesis of PAX6; electrophoretic mobility shift assays; transfection reporter assays\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro mutagenesis with DNA binding assays, mechanistically informative, single lab\",\n      \"pmids\": [\"11309364\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Pax6 directly binds the proximal promoter of Optimedin (Olfactomedin 3) through its paired domain at position -86/-70, activates Optimedin transcription, and occupies this site in vivo; mutations abolishing the binding site eliminate both Pax6 binding and promoter activation.\",\n      \"method\": \"EMSA, site-directed mutagenesis, transfection luciferase reporter assay, chromatin immunoprecipitation (ChIP)\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro binding with mutagenesis plus in vivo ChIP confirmation, multiple orthogonal methods\",\n      \"pmids\": [\"16115881\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"HIPK2 phosphorylates PAX6 at threonines 281, 304, and 373 in the C-terminal activation domain, enhancing Pax6 transactivation by promoting its interaction with p300; HIPK2 knockdown inhibits Pax6 phosphorylation and its transactivating function on the proglucagon promoter.\",\n      \"method\": \"Mass spectrometry identification of phosphorylation sites; site-directed mutagenesis (T→A, T→E); HIPK2 shRNA knockdown; co-immunoprecipitation; transactivation assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — MS identification of sites plus mutagenesis validation, co-IP, and knockdown, multiple orthogonal methods\",\n      \"pmids\": [\"16407227\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Six3 directly activates Pax6 (and Sox2) expression in the presumptive lens ectoderm, placing Six3 upstream of Pax6 at the top of the lens formation regulatory pathway; confirmed by ChIP, EMSA, luciferase reporter assay, and Six3 conditional deletion causing Pax6 downregulation.\",\n      \"method\": \"Conditional deletion of Six3 in presumptive lens ectoderm; ChIP; EMSA; luciferase reporter assay; chick misexpression\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal methods (ChIP, EMSA, reporter, in vivo deletion, ectopic expression), single rigorous study\",\n      \"pmids\": [\"17066077\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Pax6 pancreatic expression is controlled by a minimal enhancer containing a composite Meis-Pbx binding site; Meis and Pbx proteins form a synergistic complex on this enhancer, and both sites are required for enhancer activity in transgenic mice; Pax6 pancreatic expression becomes dependent on Pbx1/Pbx2 during islet formation.\",\n      \"method\": \"Enhancer deletion analysis; EMSA; transgenic mouse reporter assays; Pbx1/Pbx2 knockout analysis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — EMSA, transgenic functional validation, and genetic knockout, multiple methods in single study\",\n      \"pmids\": [\"17049510\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Pax6 is essential for lens fiber cell differentiation and cell cycle exit; conditional Pax6 inactivation in developing mouse lens leads to failure of secondary fiber differentiation, apoptosis of lens epithelial cells, and upregulation of Wnt antagonist Sfrp2 (a Pax6 target); the differentiation failure is independent of beta-catenin signaling or Sox2 activity.\",\n      \"method\": \"Cre/loxP conditional knockout in mouse lens; histology; gene expression analysis; pathway rescue experiments\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with pathway exclusion experiments, multiple molecular readouts\",\n      \"pmids\": [\"19570848\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Pax6 controls cell proliferation during newt lens regeneration; Pax6 morpholino knockdown dramatically reduces proliferation of iris pigment epithelial cells both in vitro and in vivo, retarding lens regeneration and inhibiting early crystallin expression and lens fiber induction.\",\n      \"method\": \"Morpholino knockdown in newt; BrdU proliferation assays in vitro and in vivo; crystallin immunohistochemistry\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — morpholino knockdown with multiple functional readouts, single lab\",\n      \"pmids\": [\"17003134\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"PAX6 heterozygosity causes cytoskeletal and cell adhesion defects in corneal epithelium resembling a chronic wound state: Pax6+/- corneas show altered desmoplakin and actin localization, protein oxidation, and ERK1/2 and p38 MAPK phosphorylation similar to wounded wild-type corneas.\",\n      \"method\": \"Immunohistochemistry and electron microscopy of Pax6+/- mouse corneas and wounded wild-type corneas; protein oxidation assays; MAPK phosphorylation analysis\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct comparison of mutant and wounded tissue with multiple molecular markers, single lab\",\n      \"pmids\": [\"19933176\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Pax6 regulates the proglucagon processing enzyme PC2 and its chaperone 7B2 in pancreatic alpha cells: Pax6 indirectly regulates PC2 transcription through cMaf and Beta2/NeuroD1, while it activates 7B2 both directly and indirectly through these same transcription factors.\",\n      \"method\": \"Pax6 siRNA knockdown and dominant-negative Pax6 in InR1G9 alpha cells; binding and transactivation studies; promoter analysis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RNAi knockdown with binding and transactivation assays identifying indirect pathway, single lab\",\n      \"pmids\": [\"19223471\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PAX6 is a transcriptional determinant of human neuroectoderm: PAX6 knockdown blocks NE specification from hESCs; only PAX6a (not PAX6b or PAX6deltaPD) converts hESCs to NE; PAX6a binds to NE gene promoters during human NE specification while PAX6b only binds pluripotency gene promoters.\",\n      \"method\": \"hESC differentiation; Pax6 knockdown; overexpression of isoforms; chromatin immunoprecipitation; promoter binding analysis\",\n      \"journal\": \"Cell stem cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function and isoform-specific gain-of-function with ChIP defining isoform-specific target genes, multiple orthogonal methods\",\n      \"pmids\": [\"20621053\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Pax6 regulates hindbrain segmentation by repressing Krox20 expression domains; Pax6 and Krox20 engage in mutual negative cross-talk through Pax6-mediated regulation of the Krox20 repressor Nab1; FGF signaling acts upstream of the Pax6-Krox20 network.\",\n      \"method\": \"Gain- and loss-of-function approaches in chick and mice; in situ hybridization; boundary analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple gain/loss-of-function approaches in two species identifying Nab1 as intermediate, single lab\",\n      \"pmids\": [\"23578930\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"WNT7A controls corneal epithelium differentiation through PAX6; PAX6 together with p63 specifies limbal stem cells; loss of WNT7A or PAX6 converts limbal stem cells to a skin-like epithelium; transduction of PAX6 into skin epithelial stem cells is sufficient to convert them to LSC-like cells capable of repairing corneal surface after transplantation.\",\n      \"method\": \"In vitro feeder-free LSC expansion; 3D corneal differentiation; PAX6 lentiviral transduction; rabbit corneal injury transplantation model\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — gain-of-function and loss-of-function with in vivo functional transplantation validation, multiple orthogonal methods\",\n      \"pmids\": [\"25030175\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Onecut1 and Onecut2 transcription factors operate downstream of Pax6 in retinal horizontal cell development; Pax6 inactivation in retinal progenitors leads to loss of Onecut1/2 expression, and Onecut-deficient retinae completely lack horizontal cells, placing Pax6 → Onecut1/2 → horizontal cell maintenance.\",\n      \"method\": \"Pax6 conditional knockout; Onecut1/Onecut2 single and compound mutants; immunohistochemistry for horizontal cell markers (Foxn4, Ptf1a, Prox1, Lim1)\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis established by conditional knockout and compound mutants, single lab\",\n      \"pmids\": [\"25794677\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"PAX6 maintains adult beta cell identity by directly activating beta cell genes and repressing alternative islet cell genes (ghrelin, glucagon, somatostatin); beta-cell-specific Pax6 deletion causes lethal hyperglycemia and expansion of alpha cells; lineage tracing and chromatin analysis confirm direct PAX6 binding at promoters and enhancers of repressed genes.\",\n      \"method\": \"Conditional Pax6 deletion in adult beta cells; lineage tracing; transcriptome analysis; chromatin immunoprecipitation; shRNA in human islets\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with lineage tracing, chromatin analysis, and human beta cell validation — multiple orthogonal methods\",\n      \"pmids\": [\"27941241\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Pax6 targets a large number of promoters in neural progenitor cells, many co-occupied with Sox2; Pax6 activates neuronal/ectodermal genes while concurrently repressing mesodermal and endodermal genes, ensuring unidirectional neuronal lineage commitment; Pax6 directly binds and activates Ift74, whose knockdown impairs polarity and migration of newborn neurons.\",\n      \"method\": \"ChIP-seq; transcriptome analysis in Pax6-deficient neural progenitors; in utero knockdown of Ift74\",\n      \"journal\": \"Cell discovery\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genome-wide ChIP combined with transcriptome and in vivo functional validation of downstream target\",\n      \"pmids\": [\"27462442\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"PAX6 knockout in human corneal epithelial cells (CRISPR/Cas9) leads to downregulation of cornea-specific genes (KRT12, KRT3, CLU, ALDH3A1, ANGPTL7, TKT) and upregulation of epidermis-related genes (KRT10, KRT1, IVL, FLG), demonstrating PAX6 maintains corneal epithelial cell identity.\",\n      \"method\": \"CRISPR/Cas9 PAX6 knockout in human corneal epithelial cells; microarray transcriptome analysis\",\n      \"journal\": \"Experimental eye research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CRISPR KO with genome-wide expression analysis, single lab\",\n      \"pmids\": [\"27818314\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PAX6 is upregulated in Alzheimer's disease brains downstream of amyloid-β/E2F1/c-Myb signaling and directly regulates GSK-3β transcription, promoting tau hyperphosphorylation at Ser356, Ser396, and Ser404; PAX6 downregulation protects against amyloid-β-induced neuronal death.\",\n      \"method\": \"Analysis of AD brains and APP transgenic mice; PAX6 knockdown; ChIP for E2F1, c-Myb, and PAX6 binding to GSK-3β promoter; tau phosphorylation assays\",\n      \"journal\": \"Brain : a journal of neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP, knockdown with functional readout, single lab, multiple molecular readouts\",\n      \"pmids\": [\"34428276\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"The lncRNA PAUPAR interacts with PAX6 to confer proper binding sites on target neural genes; PAX6 recruits histone methyltransferase NSD1 through its C-terminal PST domain to regulate H3K36 methylation and expression of neural target genes during cortical differentiation.\",\n      \"method\": \"hESC neural differentiation; PAUPAR knockdown; ChIP; co-immunoprecipitation; 3D cerebral organoid system\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP and ChIP demonstrating complex, single lab, mechanism partially resolved\",\n      \"pmids\": [\"33544864\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Drosophila Eyeless/Pax6 acts non-autonomously from the peripodial epithelium to control eye pattern formation by regulating decapentaplegic (dpp) expression, which is required for morphogenetic furrow initiation in the eye disc; loss of Ey in peripodial cells abolishes dpp expression and retinal development.\",\n      \"method\": \"Clonal analysis and targeted Ey knockdown/knockout in Drosophila peripodial epithelium; in situ hybridization for dpp\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function with molecular identification of downstream target (dpp), non-cell-autonomous mechanism, single lab\",\n      \"pmids\": [\"29980566\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PAX6 is a dosage-sensitive paired-box/homeodomain transcription factor that acts as a master regulator of eye, brain, and pancreas development by directly binding DNA through its paired domain and homeodomain to activate tissue-specific genes (e.g., crystallins, Optimedin, beta cell genes, GSK-3β) and repress alternative lineage genes; its transcriptional activity is enhanced by HIPK2-mediated phosphorylation at T281/T304/T373 (promoting p300 interaction), regulated by a lncRNA PAUPAR/NSD1 complex, and controlled by upstream activators including Six3 and Meis/Pbx; it functions cell-autonomously to regulate cell adhesion, migration, and cytoskeletal organization in multiple developmental contexts, and haploinsufficiency of PAX6 causes aniridia and related ocular and pancreatic dysfunction.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PAX6 is a dosage-sensitive paired-domain/homeodomain transcription factor that serves as a master regulator of eye, brain, and pancreas development, acting cell-autonomously to specify and maintain tissue identity, control cell adhesion and migration, and govern lineage commitment [#3, #26, #30]. It binds DNA through both its paired domain and homeodomain — each required for full activity, since the C-terminal Q422R mutation abolishes homeodomain binding and P375Q disrupts paired-domain binding [#16, #17] — to directly activate tissue-specific target genes such as Optimedin in the eye and beta-cell genes in the pancreas, while concurrently repressing alternative-lineage programs [#18, #30, #31]. In the developing eye PAX6 sits within mutually reinforcing regulatory loops with Six3, and dosage is tightly controlled: a critical protein threshold is required for lens placode formation, and haploinsufficiency produces lens, corneal, and migration defects [#8, #11, #20]. PAX6 enforces neuroectodermal fate in human cells in an isoform-specific manner, with PAX6a—but not PAX6b—binding neuroectoderm gene promoters and co-occupying targets with Sox2 to drive unidirectional neuronal commitment while repressing mesodermal and endodermal genes [#26, #31]. It maintains epithelial identity in the cornea, where it specifies limbal stem cells and where its loss converts corneal to skin-like epithelium [#28, #32], and it maintains adult pancreatic beta-cell identity, repressing alpha/delta-cell genes such that beta-cell deletion causes lethal hyperglycemia [#30]. PAX6 transcriptional output is tuned by post-translational and cofactor mechanisms: HIPK2 phosphorylates it at T281/T304/T373 to promote p300 interaction and transactivation, and it recruits the histone methyltransferase NSD1 (in concert with the lncRNA PAUPAR) through its C-terminal PST domain to deposit H3K36 methylation at neural targets [#19, #34]. Loss-of-function mutations in PAX6 cause human aniridia, which maps to a single locus at 11p13 [#0, #2].\",\n  \"teleology\": [\n    {\n      \"year\": 1992,\n      \"claim\": \"Establishing the genetic basis of aniridia: linkage and mutation analysis resolved that all autosomal dominant aniridia maps to a single 11p13 locus and that loss-of-function mutations in PAX6 are causative, defining PAX6 as a haploinsufficient disease gene.\",\n      \"evidence\": \"Interspecific backcross mapping of mouse Sey, expanded-kindred linkage analysis, and cDNA cloning with direct sequencing of aniridia patient DNA\",\n      \"pmids\": [\"2347591\", \"1505982\", \"1345175\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the molecular DNA-binding mechanism\", \"Did not establish the downstream target genes affected\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Resolving whether PAX6 acts within cells or on their environment: chimera analysis showed Pax6 functions cell-autonomously to control surface ectoderm fate and intermixing, framing it as an intrinsic determinant of lens, nasal, and retinal lineages.\",\n      \"evidence\": \"Chimeric mouse embryos combining wild-type and Sey mutant cells\",\n      \"pmids\": [\"8600027\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify direct transcriptional targets mediating cell-autonomy\", \"Non-autonomous roles in other tissues not excluded\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Defining PAX6 as a regulator of neuronal migration and cytoskeletal organization: loss-of-function in hindbrain, telencephalon, and cerebellar granule cells revealed roles in cell migration, polarity, and neurite extension, with Unc5h3 identified as a downstream target.\",\n      \"evidence\": \"Pax6-null and Small Eye mouse/rat analysis, focal GFP cell tracking, granule cell culture with rescue, and in situ hybridization for Unc5h3\",\n      \"pmids\": [\"10409504\", \"10572034\", \"11688562\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanistic link between PAX6 transcription and cytoskeletal change incomplete\", \"Direct vs indirect regulation of Unc5h3 not resolved\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Mapping how PAX6 expression itself is controlled and how PAX6 contacts the transcription machinery: dual promoters (P0/P1) with intron-4 elements were shown to drive tissue-specific expression, and the homeodomain was shown to bind TBP and Rb.\",\n      \"evidence\": \"Transgenic promoter-deletion reporter assays; GST pull-downs and immunoprecipitation from lens nuclear extracts\",\n      \"pmids\": [\"9847251\", \"10359315\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of the Rb interaction not established\", \"TBP interaction not validated in vivo\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Explaining dosage sensitivity mechanistically: a critical PAX6 protein threshold was shown necessary for lens placode formation, with heterozygosity causing delayed placode formation, N-cadherin failure, and apoptosis—shown not to result from monoallelic expression.\",\n      \"evidence\": \"Histology, cell counting, apoptosis assays, and allele-specific expression analysis in heterozygous Sey mouse embryos\",\n      \"pmids\": [\"11076764\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct PAX6 regulation of N-cadherin not demonstrated\", \"Threshold mechanism at the molecular level unresolved\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Dissecting the contribution of each DNA-binding module: missense mutations showed that Q422R selectively abolishes homeodomain DNA binding and P375Q disrupts paired-domain binding, establishing that both domains and the C-terminal residue are required for full function.\",\n      \"evidence\": \"Site-directed mutagenesis, EMSA, and transfection reporter assays in multiple cell lines\",\n      \"pmids\": [\"11309364\", \"14744876\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not map full target-gene repertoire dependent on each domain\", \"In vivo consequences of isolated domain loss not tested\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Placing PAX6 in cross-regulatory networks: mutual activation with Six3 in the lens (and mutual repression with Emx2 in cortex) revealed feedback loops, and Six3-driven rescue of haploinsufficiency activated the PDGF-alpha-R/cyclin D1 proliferative pathway.\",\n      \"evidence\": \"EMSA, transgenic reporter assays, Pax6+/- rescue transgenics, and loss-of-function marker analysis\",\n      \"pmids\": [\"12072567\", \"11739261\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct binding sites in Six3/Emx2 regulatory regions only partially defined\", \"Hierarchy among feedback loops in vivo unclear\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Demonstrating direct target gene activation: PAX6 was shown to bind the Optimedin promoter through its paired domain in vivo and activate transcription, providing a defined direct target with binding-site validation.\",\n      \"evidence\": \"EMSA, site-directed mutagenesis, luciferase reporter, and ChIP\",\n      \"pmids\": [\"16115881\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional role of Optimedin downstream of PAX6 not established\", \"Generalizability of paired-domain binding to other targets not shown here\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identifying post-translational and upstream control of activity: HIPK2 phosphorylation at T281/T304/T373 promotes p300 interaction and transactivation, Six3 directly activates Pax6 at the top of the lens pathway, and a Meis-Pbx enhancer controls pancreatic Pax6 expression.\",\n      \"evidence\": \"Mass spectrometry, mutagenesis, shRNA, co-IP, ChIP/EMSA, conditional and knockout mouse models, and transgenic enhancer assays\",\n      \"pmids\": [\"16407227\", \"17066077\", \"17049510\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether phosphorylation occurs in all PAX6-expressing tissues unknown\", \"Integration of upstream activators with phosphorylation not addressed\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Establishing roles in differentiation, proliferation, and tissue homeostasis: conditional knockout showed PAX6 is required for lens fiber differentiation and cell-cycle exit (via Sfrp2), morpholino knockdown showed it drives proliferation in lens regeneration, and heterozygosity produced a chronic-wound-like corneal phenotype.\",\n      \"evidence\": \"Cre/loxP conditional knockout, newt morpholino knockdown with BrdU assays, and corneal histology/MAPK analysis in Pax6+/- mice\",\n      \"pmids\": [\"19570848\", \"17003134\", \"19933176\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct vs indirect regulation of Sfrp2 incompletely resolved\", \"Single-lab observations for regeneration and corneal phenotypes\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Resolving isoform-specific function in human cell-fate decisions: PAX6a (not PAX6b or PAX6deltaPD) was shown sufficient to convert hESCs to neuroectoderm, with PAX6a binding NE gene promoters while PAX6b binds pluripotency genes.\",\n      \"evidence\": \"hESC differentiation, isoform overexpression and knockdown, and ChIP-based promoter binding analysis\",\n      \"pmids\": [\"20621053\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for isoform-specific target selection not defined\", \"Cofactors distinguishing isoform binding not identified\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Defining genome-wide target logic and adult identity maintenance: ChIP-seq revealed PAX6 co-occupies promoters with Sox2 to activate neural and repress non-neural genes (including direct activation of Ift74), and conditional deletion showed PAX6 maintains adult beta-cell identity by repressing alternative islet genes.\",\n      \"evidence\": \"ChIP-seq, transcriptome analysis, in utero knockdown, conditional beta-cell deletion with lineage tracing, and human islet shRNA\",\n      \"pmids\": [\"27462442\", \"27941241\", \"27818314\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of repression vs activation at co-occupied loci unresolved\", \"How cofactor context switches PAX6 between activation and repression unknown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Adding chromatin-modifying and disease-context mechanisms: PAX6 recruits NSD1 via its C-terminal PST domain (with lncRNA PAUPAR) to deposit H3K36 methylation at neural targets, and in Alzheimer's brains PAX6 directly drives GSK-3beta transcription to promote tau hyperphosphorylation.\",\n      \"evidence\": \"hESC/organoid differentiation with PAUPAR knockdown, co-IP and ChIP; AD brain and APP transgenic analysis with ChIP and tau phosphorylation assays\",\n      \"pmids\": [\"33544864\", \"34428276\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"NSD1/PAUPAR mechanism resolved by single-lab co-IP and ChIP\", \"Causality of PAX6 in human AD pathology not established beyond correlation and knockdown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How PAX6 context-dependently switches between gene activation and repression at co-occupied loci, and how its dosage, isoform usage, phosphorylation, and chromatin-cofactor recruitment are integrated across distinct tissues, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking domain-specific binding to activation vs repression outcomes\", \"Tissue-specific cofactor maps incomplete\", \"Structural basis of isoform-selective targeting not determined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [16, 17, 18, 26, 30, 31]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [16, 17, 18, 26, 30, 31]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [7, 18, 30]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [3, 8, 11, 28]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [18, 26, 30, 31]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [34]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"HIPK2\", \"EP300\", \"TBP\", \"RB1\", \"SIX3\", \"SOX2\", \"NSD1\", \"PAUPAR\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}